Position in BBIO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$27,162,228
+$10,424,771 QoQ
Shares Held
365,772
+13.5% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. BBIO ranks #26 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in BBIO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,162,228 | 365,772 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $16,737,457 | 322,246 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,619,948 | 245,946 | Shares | Sole | 2025-08-13 | |
| 2023-09-30 | $15,403,930 | 584,146 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $12,662,908 | 763,746 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,848,188 | 1,029,946 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,585,455 | 1,366,746 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,752,273 | 413,246 | Shares | Sole | 2022-08-12 | |
| 2021-03-31 | $7,302,433 | 118,546 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||